gadolinium dtpa has been researched along with Bright Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Damholt, MB; Dupont, A; Heaf, JG; Marckmann, P; Rossen, K; Skov, L; Thomsen, HS | 1 |
1 other study(ies) available for gadolinium dtpa and Bright Disease
| Article | Year |
|---|---|
Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging.
Topics: Adult; Aged; Female; Fibrosis; Gadolinium DTPA; Glomerulonephritis; Humans; Kidney Failure, Chronic; Magnetic Resonance Imaging; Male; Middle Aged; Pyelonephritis; Skin Diseases | 2006 |